8-124539197-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005005.3(NDUFB9):āc.11T>Gā(p.Leu4Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,614,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFB9 | NM_005005.3 | c.11T>G | p.Leu4Trp | missense_variant | 1/4 | ENST00000276689.8 | NP_004996.1 | |
NDUFB9 | NM_001311168.2 | c.11T>G | p.Leu4Trp | missense_variant | 1/4 | NP_001298097.1 | ||
NDUFB9 | NM_001278645.2 | c.-123T>G | 5_prime_UTR_variant | 1/4 | NP_001265574.1 | |||
NDUFB9 | NM_001278646.2 | c.-117T>G | 5_prime_UTR_variant | 1/4 | NP_001265575.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDUFB9 | ENST00000276689.8 | c.11T>G | p.Leu4Trp | missense_variant | 1/4 | 1 | NM_005005.3 | ENSP00000276689 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251314Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135886
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727238
GnomAD4 genome AF: 0.000171 AC: 26AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.11T>G (p.L4W) alteration is located in exon 1 (coding exon 1) of the NDUFB9 gene. This alteration results from a T to G substitution at nucleotide position 11, causing the leucine (L) at amino acid position 4 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with NDUFB9-related conditions. This variant is present in population databases (rs753001361, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces leucine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 4 of the NDUFB9 protein (p.Leu4Trp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at